|Articles|February 19, 2016
Translational Medicine: A “Team Sport”?
Author(s)DIA
February 19, 2016
Advertisement
Dr. Makoto Suematsu, President of the Japan Agency for Medical Research & Development (AMED); and Dr. Christopher P. Austin, Director of the National Center for Advancing Translational Sciences (NCATS), US National Institutes of Health; discuss how collaboration between their agencies will ultimately deliver better therapies more quickly to more patients.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
2
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape
5